CDC: babesiosis risk in northeast/upper midwest travel

July 13, 2012
CDC: babesiosis risk in northeast/Upper midwest travel
Adults and children are vulnerable to a host of tick- and mosquito-borne diseases in many Midwestern, Northeastern, and Southwestern states, according to two reports published in the July 13 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

(HealthDay) -- Adults and children are vulnerable to a host of tick- and mosquito-borne diseases in many Midwestern, Northeastern, and Southwestern states, according to two reports published in the July 13 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

Barbara L. Herwaldt, M.D., of the CDC in Atlanta, and colleagues report on the results of national surveillance in 2011 for babesiosis -- a disease that is spread either by ticks, through blood transfusions, or congenitally. The researchers found 1,124 confirmed cases in 15 of 18 states reporting the disease, with 97 percent of the cases reported in Connecticut, New Jersey, New York, Massachusetts, Rhode Island, Minnesota, and Wisconsin.

Nicole P. Lindsey, also of the CDC in Atlanta, and colleagues describe a variety of mosquito- and -borne infections, known as arboviruses, reported in 2011. West Nile virus outnumbered any other, with 712 reports, and La Crosse virus was most common in children, reported in 130. Other arboviruses reported included Powassan virus (16), St. Louis encephalitis virus (six), Eastern equine encephalitis virus (four), and Jamestown Canyon virus (three).

"West Nile virus and other arboviruses continue to cause focal outbreaks and severe illness in substantial numbers of persons in the United States," Lindsey and colleagues conclude.

Explore further: West Nile virus infections reported in Athens suburb

More information: Full Text - Babesiosis
Full Text - West Nile

Related Stories

Recommended for you

One step closer to a DNA vaccine against dengue virus

June 29, 2017

In a new study, researchers inoculated mice with a new DNA vaccine candidate (pVAX1-D1ME) in order to evaluate its efficiency. They found that the vaccine candidate was able to induce persistent humoral and cellular immune ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.